Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
EV/EBIT

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 21.6824.8716.1331.1828.05

What is the latest EV/EBIT ratio of GLAND PHARMA ?

The latest EV/EBIT ratio of GLAND PHARMA is 21.68 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202521.68
Mar202424.87
Mar202316.13
Mar202231.18
Mar202128.05

How is EV/EBIT of GLAND PHARMA Trending?

Years EV/EBIT % Change
Mar2025 21.68
-12.83
Mar2024 24.87
54.18
Mar2023 16.13
-48.27
Mar2022 31.18
11.16
Mar2021 28.05 -

Other Financial Ratios of GLAND PHARMA


Compare EV/EBIT ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹27,454.0 Cr -0.8% -6% -4.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,768.0 Cr -2.7% -2.2% -0.8% Stock Analytics
DIVIS LABORATORIES ₹169,385.0 Cr -0.7% -1.1% 7.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,242.0 Cr -0.8% 0.8% 12.2% Stock Analytics
CIPLA ₹121,093.0 Cr -1.2% -1.8% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,799.0 Cr NA 2.4% 0.2% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-0.8%

-6%

-4.5%

SENSEX

-0.4%

-0.2%

2.9%


You may also like the below Video Courses